Hongbo Guo

10.6k total citations · 3 hit papers
113 papers, 5.6k citations indexed

About

Hongbo Guo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Hongbo Guo has authored 113 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 27 papers in Pulmonary and Respiratory Medicine and 22 papers in Oncology. Recurrent topics in Hongbo Guo's work include MicroRNA in disease regulation (11 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Lung Cancer Research Studies (11 papers). Hongbo Guo is often cited by papers focused on MicroRNA in disease regulation (11 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Lung Cancer Research Studies (11 papers). Hongbo Guo collaborates with scholars based in China, Canada and United States. Hongbo Guo's co-authors include Andrew Emili, Jonathan B. Olsen, Warren C. W. Chan, Carl Walkey, Fayi Song, Rong Liu, Yoram Cohen, Ningbo Xu, Boyang Liu and Zhenyan He and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Hongbo Guo

109 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake

2011 1.6k citations Hongbo Guo, Andrew Emili et al. profile →
Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles

2014 658 citations Hongbo Guo, Andrew Emili et al. profile →
Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2‐Mediated MLH1 Intron Retention

2024 75 citations Yue Qu, Yufei Lan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hongbo Guo China	35	2.4k	1.5k	1.0k	863	824	113	5.6k
Ho‐Geun Yoon South Korea	43	3.6k 1.5×	1.7k 1.1×	1.5k 1.4×	539 0.6×	1.3k 1.5×	165	7.8k
Michelle S. Bradbury United States	31	1.7k 0.7×	1.5k 1.0×	1.8k 1.8×	451 0.5×	1.3k 1.6×	61	5.0k
Min Yang China	35	1.4k 0.6×	836 0.6×	1.9k 1.9×	321 0.4×	1.3k 1.6×	230	5.7k
Yao‐Chang Chen Taiwan	42	2.5k 1.1×	928 0.6×	952 0.9×	352 0.4×	910 1.1×	219	7.6k
Khaled Greish Bahrain	41	3.2k 1.3×	3.2k 2.2×	2.8k 2.8×	473 0.5×	1.2k 1.5×	108	7.4k
Xiankai Sun United States	45	1.7k 0.7×	979 0.7×	1.1k 1.1×	401 0.5×	1.4k 1.7×	136	5.8k
Hideki Sakai Japan	44	3.2k 1.3×	570 0.4×	712 0.7×	402 0.5×	1.0k 1.3×	323	7.4k
Anna Moore United States	40	2.5k 1.0×	1.4k 0.9×	1.7k 1.7×	515 0.6×	1.0k 1.2×	123	6.9k
Paul A. Cahill United States	49	2.1k 0.9×	678 0.5×	725 0.7×	626 0.7×	765 0.9×	203	7.2k
Marilena Loizidou United Kingdom	34	1.9k 0.8×	1.1k 0.7×	1.8k 1.8×	543 0.6×	636 0.8×	104	5.9k

Countries citing papers authored by Hongbo Guo

Since Specialization

Citations

This map shows the geographic impact of Hongbo Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbo Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbo Guo more than expected).

Fields of papers citing papers by Hongbo Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbo Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbo Guo. The network helps show where Hongbo Guo may publish in the future.

Co-authorship network of co-authors of Hongbo Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Hongbo Guo. A scholar is included among the top collaborators of Hongbo Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbo Guo. Hongbo Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Cheng, Lei Wen, Da Liu, et al.. (2025). Immunological and pathological characteristics of brain parenchymal and leptomeningeal metastases from non-small cell lung cancer. Cell Discovery. 11(1). 72–72. 1 indexed citations

Lan, Yufei, et al.. (2024). IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma. Journal of Translational Medicine. 22(1). 951–951. 1 indexed citations

Guo, Hongbo, et al.. (2024). Roles of naïve CD4+ T cells and their differentiated subtypes in lung adenocarcinoma and underlying potential regulatory pathways. Journal of Translational Medicine. 22(1). 781–781. 2 indexed citations

Liu, Zhan, Bobo Li, Cheng Feng, et al.. (2024). Neoadjuvant targeted therapy versus targeted combined with chemotherapy for resectable EGFR-mutant non–small cell lung cancer: a retrospective controlled real-world study. Frontiers in Oncology. 14. 1349300–1349300.

Zhi, Kangkang, et al.. (2023). PUM2 regulates the formation of thoracic aortic dissection through EFEMP1. Experimental Cell Research. 427(2). 113602–113602. 4 indexed citations

Jia, Wenxiao, Hongbo Guo, Min Wang, et al.. (2023). High post‐chemotherapy TIL and increased CD4+TIL are independent prognostic factors of surgically resected NSCLC following neoadjuvant chemotherapy. SHILAP Revista de lepidopterología. 4(1). e213–e213. 8 indexed citations

Lan, Yufei, et al.. (2023). IRP1 mediated ferroptosis reverses temozolomide resistance in glioblastoma via affecting LCN2/FPN1 signaling axis depended on NFKB2. iScience. 26(8). 107377–107377. 8 indexed citations

Lan, Yufei, Boyang Liu, & Hongbo Guo. (2021). The role of M6A modification in the regulation of tumor-related lncRNAs. Molecular Therapy — Nucleic Acids. 24. 768–779. 60 indexed citations

Jia, Wenxiao, Hui Zhu, Qianqian Gao, et al.. (2021). Case Report: Transformation From Cold to Hot Tumor in a Case of NSCLC Neoadjuvant Immunochemotherapy Pseudoprogression. Frontiers in Immunology. 12. 633534–633534. 8 indexed citations

10.

Lian, Changlin, Huijun Zeng, Boyang Liu, et al.. (2021). SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity via GLS-Mediated Glutaminolysis. Frontiers in Oncology. 11. 698835–698835. 24 indexed citations

11.

Kuzmanov, Uroš, Erika Yan Wang, Rachel D. Vanderlaan, et al.. (2020). Mapping signalling perturbations in myocardial fibrosis via the integrative phosphoproteomic profiling of tissue from diverse sources. Nature Biomedical Engineering. 4(9). 889–900. 26 indexed citations

12.

He, Zhenyan, Yong Gao, Amber L. Alhadeff, et al.. (2018). Cellular and synaptic reorganization of arcuate NPY/AgRP and POMC neurons after exercise. Molecular Metabolism. 18. 107–119. 68 indexed citations

13.

Schmitges, Frank W., Ernest Radovani, Hamed S. Najafabadi, et al.. (2016). Multiparameter functional diversity of human C2H2 zinc finger proteins. Genome Research. 26(12). 1742–1752. 125 indexed citations

14.

Wells, Laura A., Hongbo Guo, Andrew Emili, & Michael V. Sefton. (2016). The profile of adsorbed plasma and serum proteins on methacrylic acid copolymer beads: Effect on complement activation. Biomaterials. 118. 74–83. 33 indexed citations

15.

Liu, Yanting, Ningbo Xu, Boyang Liu, et al.. (2016). Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines. Oncotarget. 7(28). 43835–43851. 49 indexed citations

16.

Rakhit, Rishi, Hongbo Guo, Yulong Sun, et al.. (2015). Determining composition of micron-scale protein deposits in neurodegenerative disease by spatially targeted optical microproteomics. eLife. 4. 34 indexed citations

17.

Gao, Yuan, Pingping Song, Baijiang Zhang, et al.. (2015). Epidermal growth factor receptor tyrosine kinase inhibitors with conventional chemotherapy for the treatment of non-small cell lung cancer. OncoTargets and Therapy. 9. 13–13. 2 indexed citations

18.

Liu, Tianzhu, Xin Wang, Yifeng Bai, et al.. (2014). The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor. The International Journal of Biochemistry & Cell Biology. 49. 8–16. 36 indexed citations

19.

Huang, Lianyan, et al.. (2009). ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity. Carcinogenesis. 30(5). 737–744. 74 indexed citations

20.

Jiang, Haiping, Jinming Yu, Hongbo Guo, Hao Song, & Shaoqing Chen. (2007). Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells. Biochemical and Biophysical Research Communications. 368(1). 1–5. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact